Search

Series:

Glaucoma Case Files

Surgical Insights and Real Cases From the OR

Editorially Independent Content, Supported with Advertising from Allergan XEN, Glaukos iDose & Nova Eye.

iDose TR: Patient Selection, Procedure Pearls, and Clinical Benefits

Rachel G. Simpson, MD; and Roya Garakani, DO

Show Description +

Rachel G. Simpson, MD, and Roya Garakani, DO, discuss the role of the iDose TR (Glaukos) procedural pharmaceutical, offering pearls for patient selection and implantation. Dr. Simpson explains how the iDose can benefit patients with poor medication compliance and minimizes ocular surface side effects observed with other topical drops. She also comments on how the implantation procedure differs from that of the iStent (Glaukos), and the use of iDose as a standalone or combination surgery.

Posted: 11/12/2025

Keywords:

Sustained Drug Delivery

•

iDose TR

•

Durysta

•

Drop Compliance

•

Procedural Pharmaceutical

Up Next

Exploring Surgical Options for a Young Glaucoma Patient

Exploring Surgical Options for a Young Glaucoma Patient

Rachel G. Simpson, MD; Roya Garakani, DO; and Craig J. Chaya, MD

Endoscopic Cyclophotocoagulation in a Challenging Case of Neovascular Glaucoma

Endoscopic Cyclophotocoagulation in a Challenging Case of Neovascular Glaucoma

Rachel G. Simpson, MD; and Roya Garakani, DO

Cataract Surgery With a Pre-Existing Filtering Bleb

Cataract Surgery With a Pre-Existing Filtering Bleb

Rachel G. Simpson, MD; and Roya Garakani, DO

Combination MIGS Procedures

Combination MIGS Procedures

Rachel G. Simpson, MD; Roya Garakani, DO; and Craig J. Chaya, MD

Explantation and Reimplantation of a Tube Shunt

Explantation and Reimplantation of a Tube Shunt

Rachel G. Simpson, MD; and Roya Garakani, DO

Revision of an Ischemic Focal Bleb

Revision of an Ischemic Focal Bleb

Rachel G. Simpson, MD; and Roya Garakani, DO

Surgical Insights and Patient Selection for AlloFlo

Surgical Insights and Patient Selection for AlloFlo

Rachel G. Simpson, MD; Roya Garakani, DO; and Craig J. Chaya, MD

Optimizing Existing Tube Shunt in Uveitic Glaucoma

Optimizing Existing Tube Shunt in Uveitic Glaucoma

Rachel G. Simpson, MD; and Roya Garakani, DO

Patient Selection and Pearls for Trabeculectomy

Patient Selection and Pearls for Trabeculectomy

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

An Unexpected Encounter With Angle Recession

An Unexpected Encounter With Angle Recession

Manjool Shah, MD; Arsham Sheybani, MD; and Jonathan S. Williams, MD

Xen Gel Stent Revision and Ahmed Valve Implantation

Xen Gel Stent Revision and Ahmed Valve Implantation

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

GATT for Juvenile Open-Angle Glaucoma

GATT for Juvenile Open-Angle Glaucoma

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Phacoemulsification and iTrack Advance Canaloplasty

Phacoemulsification and iTrack Advance Canaloplasty

Manjool Shah, MD; Arsham Sheybani, MD; and Jonathan S. Williams, MD

Surgical Approaches for Ahmed Glaucoma Valve Implantation

Surgical Approaches for Ahmed Glaucoma Valve Implantation

Manjool Shah, MD; Arsham Sheybani, MD; and Jonathan S. Williams, MD

Trabeculectomy Revision With Phacoemulsification

Trabeculectomy Revision With Phacoemulsification

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Xen Gel Stent Implantation Pearls

Xen Gel Stent Implantation Pearls

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Phacoemulsification and Hydrus Implantation

Phacoemulsification and Hydrus Implantation

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

iStent Placement Techniques

iStent Placement Techniques

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Talking Tubes

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Ahmed Glaucoma Valve to Mitigate Post-Injection IOP Elevation

Ahmed Glaucoma Valve to Mitigate Post-Injection IOP Elevation

Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Premiere Episode: IOP Spike After Routine Cataract Surgery

Premiere Episode: IOP Spike After Routine Cataract Surgery

Joe Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD

Back to All Videos

iDose TR: Patient Selection, Procedure Pearls, and Clinical Benefits

Rachel G. Simpson, MD; and Roya Garakani, DO

Rachel G. Simpson, MD, and Roya Garakani, DO, discuss the role of the iDose TR (Glaukos) procedural pharmaceutical, offering pearls for patient selection and implantation. Dr. Simpson explains how the iDose can benefit patients with poor medication compliance and minimizes ocular surface side effects observed with other topical drops. She also comments on how the implantation procedure differs from that of the iStent (Glaukos), and the use of iDose as a standalone or combination surgery.

Posted: 11/12/2025

Keywords:

Sustained Drug Delivery

•

iDose TR

•

Durysta

•

Drop Compliance

•

Procedural Pharmaceutical

Please log in to leave a comment.